Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience

Head and Neck Cancer

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)

J Natl Cancer Inst

Williamson A, Brady G, Harris N, Haris PA, Bisase B, Chiu K, Douglas C, Fleming J, Hamilton D, Haridass A, Hughes C, Iqbal MS, Kerawala C, King E, Liu Z, McCaul J, Montgomery J, Nankivell P, Nixon I, Noble D, Nugent M, Paterson C, Pracy P, Riva F, Roe J, Schache A, Selbong U, Schilling C, Simo R, Winter S, O'Leary B, Paleri V

doi: 10.1093/jnci/djaf128

Head and Neck Cancer

Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group

Eur J Cancer

Tinhofer I, Hofmann E, Trelinska-Finger A, Saraei T, Keilholz U, Heiland M, Letsch A, Knödler M, Beck M, Klinghammer K, Dommerich S, Wittenberg I, Reinwald F, Sackmann A, Klinkhammer-Schalke M, Zeissig SR, Weitmann K, Franke B, Schneider C, Zips D, Doll C

doi: 10.1016/j.ejca.2025.116039

Head and Neck Cancer

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

J Clin Oncol

Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tân PF, Siu LL, Holsinger FC, El-Naggar A, Chung C, Cmelak A, Burtness B, Bednarz G, Quon H, Breen SL, Gwede CK, Dicker AP, Yao M, Jordan RC, Dorth J, Lee N, Chan JW, Dunlap N, Bar-Ad V, Stokes WA, Chakravarti A, Sher D, Rao S, Harris J, Yom SS, Le QT, NRG Oncology RTOG 0920 Collaborating Team, TransSCOT Consortium

doi: 10.1200/JCO-24-01829

Head and Neck Cancer

Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Eur J Cancer

Nielsen SB, Lyhne NM, Andersen M, Plaschke CC, Gothelf AB, Johansen J, Maare C, Farhadi M, Godballe C, Primdahl H, Holm AIS, Alsner J, Kjærgaard T, Overgaard J

doi: 10.1016/j.ejca.2024.115211

Head and Neck Cancer

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers

Clin Cancer Res

Bryan ME, Aye L, Das D, Hirayama S, Al-Inaya Y, Mendel J, Naegele S, Efthymiou V, Alzumaili B, Faquin WC, Sadow PM, Lin D, Varvares MA, Feng AL, Deschler DG, Chan AW, Paly J, Park JC, Roberts T, Merkin R, Mishra SK, Kröller L, Michels B, Iafrate AJ, Wirth LJ, Adalsteinsson VA, Crowson M, Waterboer T, Mirabello L, Lawrence MS, Guan Z, Fisch AS, Richmon JD, Faden DL

doi: 10.1158/1078-0432.CCR-24-2525

Head and Neck Cancer

Patient-related prognostic factors in older adults with head and neck cancer: The EGeSOR clinical trial

Eur J Cancer

Lafont C, Paillaud E, Jean C, Bertolus C, Baron M, Caillet P, Bouvard E, Laurent M, Salvan D, Chaumette L, de Decker L, Piot B, Barry B, Raynaud-Simon A, Sauvaget E, Minard A, Brugel L, Canouï-Poitrine F

doi: 10.1016/j.ejca.2025.115630

Head and Neck Cancer

Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer

Clin Cancer Res

Sim ES, Rhoades J, Xiong K, Walsh L, Crnjac A, Blewett T, Al-Inaya Y, Mendel J, Ruiz-Torres DA, Efthymiou V, Lumaj G, Benjamin WJ, Makrigiorgos GM, Tabrizi S, Adalsteinsson VA, Faden DL

doi: 10.1158/1078-0432.CCR-25-0307

Gynecologic Cancer

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Eur J Cancer

Hardie AN, Wenzel HHB, Schnack TH, Van der Aa MA, Jensen PT, Bekkers RLM, Falconer H, Dutch, dANish and sweDish gynaEcoLogIcal ONcology (DANDELION) research group

doi: 10.1016/j.ejca.2025.115664

Head and Neck Cancer

Re-examining Post-operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931

Ann Oncol

Zumsteg ZS, Luu M, Fortpied C, Jang JK, Chen MM, Mallen-St Clair J, Walgama E, Le QT, Machtay M, Tribius S, Forastiere A, Wong S, Ozsahin EM, Gregoire V, Vermorken JB, Ho AS, Yom SS

doi: 10.1016/j.annonc.2025.07.004

Related content

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)

Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers

Patient-related prognostic factors in older adults with head and neck cancer: The EGeSOR clinical trial

Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Re-examining Post-operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931